| Mrs Zilda Brewer Wilson, MA, CCC/SLP | |
|
53 Woodbriar Ct, Nicholasville, KY 40356-9194 | |
| (859) 223-2429 | |
| Not Available |
| Full Name | Mrs Zilda Brewer Wilson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 53 Woodbriar Ct, Nicholasville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154692705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3580 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Zilda Brewer Wilson, MA, CCC/SLP 53 Woodbriar Ct, Nicholasville, KY 40356-9194 Ph: (859) 223-2429 | Mrs Zilda Brewer Wilson, MA, CCC/SLP 53 Woodbriar Ct, Nicholasville, KY 40356-9194 Ph: (859) 223-2429 |
News Archive
Researchers at Yale have identified a possible treatment for Duchenne muscular dystrophy (DMD), a rare genetic disease for which there is currently no cure or treatment, by targeting an enzyme that had been considered "undruggable."
Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
Light long has been used to treat cancer. But phototherapy is only effective where light easily can reach, limiting its use to cancers of the skin and in areas accessible with an endoscope, such as the gastrointestinal tract.
› Verified 9 days ago
Amber Driver, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 799 E Brannon Rd, Nicholasville, KY 40356 Phone: 859-224-2273 Fax: 859-224-4675 | |
Brittany Yancy, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Sparks Ave, Nicholasville, KY 40356 Phone: 859-885-4171 | |
Samantha Palmer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 109 Wind Haven Dr, Nicholasville, KY 40356 Phone: 859-224-2273 | |
Ms. Elizabeth Hoskins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Wind Haven Dr, Suite 1, Nicholasville, KY 40356 Phone: 859-224-2273 | |
Sarah Littleton-hines, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 109 Wind Haven Dr Ste 100, Nicholasville, KY 40356 Phone: 859-224-2273 Fax: 859-224-4675 | |
Madeline Cole, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Spring Crest Dr, Nicholasville, KY 40356 Phone: 859-401-2660 |